All In Biotech

Drug Trial Radar · NCT06246513

A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4

A Phase 3 Multinational, Open-label, Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9003 in Subjects With Limb Girdle Muscular Dystrophy 2E/R4

Last checked: Nov 19, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

17

Actual

Start

Jan 15, 2024

Primary completion

Mar 4, 2025

Study completion Nov 30, 2029

Sponsor

Lead sponsor
Sarepta Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Feb 7, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, global study of the effects of a single systemic dose of SRP-9003 on beta-sarcoglycan (β-SG) gene expression in participants with limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4). This study will consist of both ambulatory participants (Cohort 1) and non-ambulatory participants (Cohort 2).

Conditions

  • Limb-girdle Muscular Dystrophy

Interventions

  • SRP-9003Biological

    Solution for single IV infusion

  • GlucocorticoidDrug

    Oral tablet (prophylactic)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cohort 1: Change from Baseline in β-SG Expression at Day 60 Post-dose as Measured by Immunofluorescence (IF) Percent β-SG Positive FibersTime frame: Baseline, Day 60

Locations

10 sites in 6 countries. Site status is shown where the registry gives one.

  • University of California, San Diego-Altman Clinical and Translational Research Institute

    La Jolla, California

  • Nationwide Childrens Hospital

    Columbus, Ohio

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Children's Hospital of The King's Daughter

    Norfolk, Virginia

  • NMRC Gent (UZ Gent)

    Ghent, Belgium

  • University Hospital Leuven (UZ Leuven)

    Leuven, Vlaams Brabant, Belgium

  • Universitatsklinikum Essen; Kinderklinik I, Sozialpadiatrisches Zentrum

    Essen, North Rhine-Westphalia, Germany

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • Hospital Sant Joan de Deu

    Barcelona, Spain

  • Newcastle University

    Newcastle upon Tyne, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.